Infleqtion Reports Record Q1 Revenue as Customer Demand Accelerates
Updating 2026 revenue outlook to at least
First Quarter 2026 Financial Highlights
-
Record Q1 revenue of
$9.5 million , up 14% year over year; 100% organic and 100% from quantum -
GAAP loss from operations of
$33.6 million -
Non-GAAP loss from operations of
$13.2 million , which excludes stock-based compensation, acquisition and integration costs and go-public transaction expenses -
Net cash used in operations of
$19.2 million with capital expenditures of$0.3 million -
Cash, cash equivalents and available-for-sale securities of
$569 million as ofMarch 31, 2026
Updated 2026 Guidance
-
Increased revenue guidance for 2026 to at least
$40 million supported by expanding customer activity across the Company's quantum portfolio
Recent Milestones and Commercial Progress
-
Announced Infleqtion’s role as a collaborator on
NASA JPL’s Quantum Gravity Gradiometer Pathfinder mission, supported by$20 million in contracts to date -
Delivered upgraded quantum hardware for NASA’s
Cold Atom Lab aboard theInternational Space Station building on Infleqtion’s quantum technology operating aboard the ISS since 2018 -
Announced availability of a first-of-its-kind partnership for quantum-enabled precision timing solution with
Safran Electronics & Defense , integrating Infleqtion’s Tiqker™ quantum optical clock with Safran’s White Rabbit and SecureSync® systems to deliver resilient timing for mission-critical systems in GNSS-challenged environments - Announced the acceleration of Quantum Spectrum, the Company’s atom-based RF sensing platform, in response to growing customer interest. Quantum Spectrum was the second-largest contributor to sensing revenue, with multiple new customer programs addressing demand for trusted signals and resilient communication in contested environments
- Expanded Infleqtion’s quantum software programs across defense, energy, and research customers, including a milestone win with the DARPA HARQ program. New engagements span compiler development, energy-grid optimization, and computational chemistry
-
Contracted with the
U.S. Navy to advance Infleqtion’s Contextual Machine Learning software for RF signal processing, with development underway toward an integrated prototype -
Selected for two
U.S. Department of Energy programs to advance quantum computing applications in chemistry, materials science, and energy grid optimization, addressing markets representing trillions of dollars in global economic value - Advanced Infleqtion’s collaboration with NVIDIA through adoption of NVIDIA Ising AI models for quantum processor calibration and error-correction decoding on the Company’s Sqale neutral-atom quantum computer
- Began trading on the NYSE under the symbol "INFQ" as the first publicly traded neutral-atom quantum computing company, marking a new chapter in the commercialization of quantum technology
“Q1 reinforced our confidence that quantum is gaining momentum as the market shifts toward deployable systems, real applications, and measurable customer value,” said
“First quarter revenue of
Conference Call and Webcast Information
The Company will host a conference call at
Conference Call Details
Live Call
Domestic Dial-In: 1-877-869-3847
International Dial-In: 1-201-689-8261
Replay
Domestic Dial-In: 1-877-660-6853
International Dial-In: 1-201-612-7415
Conference ID: 13760305
Webcast
Event URL: https://event.webcasts.com/starthere.jsp?ei=1761121&tp_key=0124651085
The replay will be available approximately three hours after the conclusion of the conference call through
Upcoming Speaking and Event Participation
-
J.P. Morgan Global Technology Conference -Wednesday, May 20 inBoston, MA -
Canaccord Virtual Quantum Symposium -
May 21, 2026 -
American Physical Society DAMOP Annual Meeting -
June 1-5 inProvidence, RI -
Evercore Global TMT Conference -June 2 inSan Francisco, CA -
Quantum Fringe -
June 10-12 inEdinburgh, Scotland -
Economist Impact Commercializing Quantum Global 2026 -
June 16-17 inLondon, UK -
Global Quantum Forum –July 21-23 inChicago, IL
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited; in thousands, except share and per share amounts)
|
|
|
Three months ended |
|||
|
|
|
|
2026 |
|
2025 |
|
|
|
|
|
|
|
|
Total revenue |
|
$ |
9,461 |
$ |
8,303 |
|
Total cost of revenue |
|
|
7,470 |
|
4,926 |
|
Gross profit |
|
|
1,991 |
|
3,377 |
|
Research and development |
|
|
9,951 |
|
5,167 |
|
Selling, general and administrative |
|
|
26,320 |
|
5,784 |
|
Grant income |
|
|
(705) |
|
(624) |
|
Loss from operations |
|
|
(33,575) |
|
(6,950) |
|
Other income (expense): |
|
|
|
|
|
|
Interest income |
|
|
3,202 |
|
356 |
|
Other, net |
|
|
110 |
|
609 |
|
Total other income, net |
|
|
3,312 |
|
965 |
|
Loss before income taxes |
|
|
(30,263) |
|
(5,985) |
|
Income tax expense (benefit) |
|
|
- |
|
- |
|
Net loss |
|
$ |
(30,263) |
$ |
(5,985) |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
Unrealized loss on available-for-sale securities |
|
|
(882) |
|
- |
|
Foreign currency translation adjustment |
|
|
(99) |
|
416 |
|
Total other comprehensive (loss) income |
|
|
(981) |
|
416 |
|
Comprehensive loss |
|
$ |
(31,244) |
$ |
(5,569) |
|
|
|
|
|
|
|
|
Net loss per share attributable to common stockholders - basic and diluted |
|
$ |
(0.26) |
$ |
(0.41) |
|
Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted |
|
|
118,162,332 |
|
14,737,927 |
The accompanying notes are an integral part of these condensed consolidated financial statements
Condensed Consolidated Balance Sheets
(Unaudited; in thousands, except share and per share amounts)
|
|
|
As of |
|||
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
84,674 |
$ |
11,694 |
|
Available-for-sale securities, current |
|
|
358,866 |
|
34,318 |
|
Accounts receivable |
|
|
6,858 |
|
9,543 |
|
Unbilled receivables |
|
|
4,979 |
|
4,734 |
|
Inventories |
|
|
4,869 |
|
4,299 |
|
Prepaid expenses and other current assets |
|
|
4,630 |
|
10,036 |
|
Total current assets |
|
|
464,876 |
|
74,624 |
|
Property and equipment, net |
|
|
8,045 |
|
8,674 |
|
Operating lease right-of-use assets |
|
|
4,680 |
|
4,923 |
|
Available-for-sale securities, non-current |
|
|
125,117 |
|
17,157 |
|
|
|
|
9,315 |
|
9,315 |
|
Other assets |
|
|
578 |
|
620 |
|
TOTAL ASSETS |
|
$ |
612,611 |
$ |
115,313 |
|
|
|
|
|
|
|
|
LIABILITIES, CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) |
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
Accounts payable |
|
$ |
3,718 |
$ |
5,644 |
|
Accrued liabilities |
|
|
9,803 |
|
8,610 |
|
Contract liabilities |
|
|
8,942 |
|
6,871 |
|
Current portion of operating lease right-of-use liabilities |
|
|
1,088 |
|
1,076 |
|
Deferred consideration payable, current |
|
|
- |
|
471 |
|
Total current liabilities |
|
|
23,551 |
|
22,672 |
|
Operating lease liabilities, net of current portion |
|
|
3,805 |
|
4,074 |
|
TOTAL LIABILITIES |
|
|
27,356 |
|
26,746 |
|
Convertible Redeemable Preferred Stock: |
|
|
|
|
|
|
Series Seed convertible redeemable preferred stock, |
|
|
- |
|
6,526 |
|
Series Seed II convertible redeemable preferred stock; |
|
|
- |
|
10,411 |
|
Series A convertible redeemable preferred stock, |
|
|
- |
|
36,658 |
|
Series B convertible redeemable preferred stock; |
|
|
- |
|
112,145 |
|
Series B-1 convertible redeemable preferred stock; |
|
|
- |
|
32,990 |
|
Series C convertible redeemable preferred stock; |
|
|
- |
|
71,733 |
|
Series C-1 convertible redeemable preferred stock; |
|
|
- |
|
26,351 |
|
Total Convertible Redeemable Preferred Stock |
|
|
- |
|
296,814 |
|
Commitments and contingencies (refer to note 9) |
|
|
|
|
|
|
Stockholders' Equity (Deficit): |
|
|
|
|
|
|
Preferred stock: |
|
|
- |
|
- |
|
Common stock: |
|
|
22 |
|
2 |
|
Additional paid-in capital |
|
|
846,657 |
|
21,931 |
|
Accumulated deficit |
|
|
(261,349) |
|
(231,086) |
|
Accumulated other comprehensive (loss) income |
|
|
(75) |
|
906 |
|
Total Stockholders' Equity (Deficit) |
|
|
585,255 |
|
(208,247) |
|
Total Liabilities, Convertible Redeemable Preferred Stock and Stockholders' Equity (Deficit) |
|
$ |
612,611 |
$ |
115,313 |
The accompanying notes are an integral part of these condensed consolidated financial statements
Condensed Consolidated Statements of Cash Flows
(Unaudited; in thousands)
|
|
|
Three months ended |
|||
|
|
|
|
2026 |
|
2025 |
|
Cash flows from operating activities |
|
|
|
|
|
|
Net loss |
|
$ |
(30,263) |
$ |
(5,985) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
Depreciation and amortization expense |
|
|
948 |
|
701 |
|
Stock-based compensation expense |
|
|
8,293 |
|
1,118 |
|
Change in fair value of contingent obligation |
|
|
631 |
|
- |
|
Other non-cash operating adjustments |
|
|
(742) |
|
(328) |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
Accounts receivable |
|
|
2,658 |
|
1,931 |
|
Unbilled receivables |
|
|
(255) |
|
(2,699) |
|
Inventories |
|
|
(570) |
|
(1,112) |
|
Prepaid expenses and other current assets |
|
|
181 |
|
675 |
|
Other assets |
|
|
35 |
|
(13) |
|
Accounts payable |
|
|
(1,915) |
|
2,507 |
|
Accrued liabilities |
|
|
(216) |
|
(2,492) |
|
Contract liabilities |
|
|
2,071 |
|
(1,070) |
|
Operating lease right-of-use assets |
|
|
189 |
|
127 |
|
Operating lease right-of-use liabilities |
|
|
(204) |
|
(332) |
|
Net cash used in operating activities |
|
|
(19,159) |
|
(6,972) |
|
Cash flows from investing activities |
|
|
|
|
|
|
Purchases of available-for-sale securities |
|
|
(444,153) |
|
- |
|
Maturities of available-for-sale securities |
|
|
11,400 |
|
- |
|
Purchases of property and equipment |
|
|
(312) |
|
(408) |
|
Net cash used in investing activities |
|
|
(433,065) |
|
(408) |
|
Cash flows from financing activities |
|
|
|
|
|
|
Proceeds from stock options exercised |
|
|
771 |
|
371 |
|
Payment of offering costs |
|
|
(3,306) |
|
- |
|
Proceeds from recapitalization, net of redemptions |
|
|
528,166 |
|
- |
|
Payment of cash consideration |
|
|
(475) |
|
(713) |
|
Net cash provided by (used in) financing activities |
|
|
525,156 |
|
(342) |
|
Foreign currency translation |
|
|
48 |
|
763 |
|
Net increase (decrease) in cash and cash equivalents and restricted cash |
|
$ |
72,980 |
$ |
(6,959) |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
$ |
11,894 |
$ |
48,142 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
84,874 |
$ |
41,183 |
|
Supplemental non-cash disclosure of cash flow information |
|
|
|
|
|
|
Conversion of preferred stock to common stock |
|
$ |
(296,814) |
$ |
- |
|
Reclassification of deferred offering costs in connection with business combination |
|
$ |
(9,298) |
$ |
- |
|
Unpaid offering costs |
|
$ |
786 |
$ |
- |
|
Unrealized gains or losses on available-for-sale securities |
|
$ |
(882) |
$ |
- |
The accompanying notes are an integral part of these condensed consolidated financial statements
Reconciliation of Non-GAAP Financial Measures
(in thousands)
The following is a reconciliation of non-GAAP measures of
|
|
|
|
|
|
Three Months ended |
|||||
|
|
|
|
|
|
2026 |
|
2025 |
|||
|
Cost of Revenue |
|
|
|
|
$ |
7,470 |
|
|
$ |
4,926 |
|
Adjustments: |
|
|
|
|
|
|
|
|
||
|
Stock-based compensation |
|
|
|
|
|
1,017 |
|
|
|
92 |
|
Acquisition and integration costs |
|
|
|
|
|
|
|
- |
||
|
Non-GAAP Cost of Revenue |
|
|
|
$ |
6,453 |
|
|
$ |
4,834 |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Three Months ended |
|||||
|
|
|
|
|
|
2026 |
|
2025 |
|||
|
R&D |
|
|
|
|
$ |
9,951 |
|
|
$ |
5,167 |
|
Adjustments: |
|
|
|
|
|
|
|
|
||
|
Stock-based compensation |
|
|
|
|
|
2,414 |
|
|
|
72 |
|
Acquisition and integration costs |
|
|
|
|
- |
|
|
|
- |
|
|
Non-GAAP R&D |
|
|
|
|
$ |
7,537 |
|
|
$ |
5,095 |
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Three Months ended |
|||||
|
|
|
|
|
|
2026 |
|
2025 |
|||
|
SG&A |
|
|
|
|
$ |
26,320 |
|
|
$ |
5,784 |
|
Adjustments: |
|
|
|
|
|
|
|
|
||
|
Stock-based compensation |
|
|
|
|
|
4,862 |
|
|
|
954 |
|
Acquisition and integration costs |
|
|
|
|
631 |
|
|
|
- |
|
|
Go-public transaction expenses |
|
|
|
|
|
11,466 |
|
|
|
- |
|
Non-GAAP SG&A |
|
|
|
|
$ |
9,361 |
|
|
$ |
4,830 |
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Three Months ended |
|||||
|
|
|
|
|
|
2026 |
|
2025 |
|||
|
Loss from operations |
|
|
|
|
$ |
(33,575) |
|
|
$ |
(6,950) |
|
Adjustments: |
|
|
|
|
|
|
|
|
||
|
Stock-based compensation |
|
|
|
|
|
8,293 |
|
|
|
1,118 |
|
Acquisition and integration costs |
|
|
|
|
631 |
|
|
|
- |
|
|
Go-public transaction expenses |
|
|
|
|
|
11,466 |
|
|
|
- |
|
Non-GAAP operating loss |
|
|
|
$ |
(13,185) |
|
|
$ |
(5,832) |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Three Months ended |
|||||
|
|
|
|
|
|
2026 |
|
2025 |
|||
|
Net loss |
|
|
|
|
$ |
(30,263) |
|
|
$ |
(5,985) |
|
Adjustments: |
|
|
|
|
|
|
|
|
||
|
Stock-based compensation |
|
|
|
|
|
8,293 |
|
|
|
1,118 |
|
Acquisition and integration costs |
|
|
|
|
631 |
|
|
|
- |
|
|
Go-public transaction expenses |
|
|
|
|
|
11,466 |
|
|
|
- |
|
Non-GAAP Net loss |
|
|
|
|
$ |
(9,873) |
|
|
$ |
(4,867) |
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws, including the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "anticipates," "believes," "plans," "seeks," "will" and variations of these words or similar expressions that are intended to identify forward-looking statements. All statements, other than statements of historical facts, including without limitation statements regarding the Company’s expected 2026 revenue, business outlook, customer demand, commercial opportunities, and market momentum. These statements are based on Infleqtion’s current expectations, assumptions and projections as of the date of this release and are subject to risks and uncertainties that could cause actual results to differ materially and adversely. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Such risks and uncertainties include, without limitation, those related to Infleqtion’s ability to recognize anticipated benefits of its business combination with
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures.
“Non-GAAP operating loss” is defined as loss from operations adjusted to add back, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, and impairment of assets and goodwill.
“Non-GAAP net loss” is defined as net loss adjusted to add back, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, change in fair value of contingent consideration, change in fair value of SAFE liabilities, and impairment of assets and goodwill.
See “Reconciliation of Non-GAAP Financial Measures” in this press release for reconciliations of these non-GAAP measures to the most directly comparable GAAP measures.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20260514397902/en/
Investor Contact
investors@infleqtion.com
Media Contact
sknight@soleburystrat.com
Source: